Indonesia on Friday received a total of 6.5 million doses of the COVID-19 vaccine in three shipments from Pfizer, AstraZeneca, and Sinovac. “Today’s arrival added Indonesia’s (vaccine) supply in both
The spread of disinformation regarding vaccinations has led to the slow progress in vaccinations among the elderly in the country, spokesperson for COVID-19 vaccinations at the Ministry of Health, Siti
Governor Anies Baswedan has asked the 190-member Jakarta contingent participating in the 16th National Para Games (Peparnas), due to be held in Papua province on November 2-15, 2021, to maintain
DSFR Partner with Tibc DSFR has completed its Initial Exchange Offering (IEO) on Latoken 10th October 2021 listed to trade in Latoken and coinsbit.io Exchanges The DSFR blockchain project focuses on bringing crypto adoption to the retail industry. The blockchain platform has an extensive ecosystem that consists of an integrated
New Schneider Electric report outlines “Back to 2050” decarbonization scenarios Schneider experts on the ground in Glasgow to advance decarbonization insights and solutions with business partners, climate experts and influencers Rueil-Malmaison (France), October 29 2021 – Schneider Electric, the leader in the digital transformation of energy management and automation, is
Corporate security teams face a critical juncture Cobwebs Technologies NEW YORK, Oct. 29, 2021 (GLOBE NEWSWIRE) — The following is an open letter from Cobwebs Technologies – a global leader in Web Intelligence. Today, the array of threats posed to disrupt businesses only intensifies, while the systems and methods organizations
SINGAPORE, Oct. 28, 2021 (GLOBE NEWSWIRE) — Ibanera, a global digital banking platform and financial services provider, announced that it will offer fintech services to customers in Singapore with a focus on domestic and cross-border money transfer services. The company offers a robust suite of compliance programs for transaction monitoring
MAYFIELD, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — JT Medical (the “Company”), JT Medical announces that it is now accepting memorandums of understanding (MOUs) from researchers wishing to secure high quality, repeatable batch, plant-based medical products derived from regulated plants, including but not limited to, cannabis, psilocybin